Use of Ultrasound and Ki–67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy

por Liebscher, Sean C., Kilgore, Lyndsey J., Winblad, Onalisa, Gloyeske, Nika, Larson, Kelsey, Balanoff, Christa, Nye, Lauren, O’Dea, Anne, Sharma, Priyanka, Kimler, Bruce, Khan, Qamar, Wagner, Jamie
Publicado 2023

ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease

por Stecklein, Shane R., Kimler, Bruce F., Yoder, Rachel, Schwensen, Kelsey, Staley, Joshua M., Khan, Qamar J., O’Dea, Anne P., Nye, Lauren E., Elia, Manana, Heldstab, Jaimie, Home, Trisha, Hyter, Stephen, Isakova, Kamilla, Pathak, Harsh B., Godwin, Andrew K., Sharma, Priyanka
Publicado 2023

Rapid Escalation of High-Volume Exercise during Caloric Restriction; Change in Visceral Adipose Tissue and Adipocytokines in Obese Sedentary Breast Cancer Survivors

por Fabian, Carol J., Klemp, Jennifer R., Marchello, Nicholas J., Vidoni, Eric D., Sullivan, Debra K., Nydegger, Jennifer L., Phillips, Teresa A., Kreutzjans, Amy L., Hendry, Bill, Befort, Christie A., Nye, Lauren, Powers, Kandy R., Hursting, Stephen D., Giles, Erin D., Hamilton-Reeves, Jill M., Li, Bing, Kimler, Bruce F.
Publicado 2021

Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer

por Yoder, Rachel, Kimler, Bruce F., Staley, Joshua M., Schwensen, Kelsey, Wang, Yen Y., Finke, Karissa, O’Dea, Anne, Nye, Lauren, Elia, Manana, Crane, Gregory, McKittrick, Richard, Pluenneke, Robert, Madhusudhana, Sheshadri, Beck, Larry, Shrestha, Anuj, Corum, Larry, Marsico, Mark, Stecklein, Shane R., Godwin, Andrew K., Khan, Qamar J., Sharma, Priyanka
Publicado 2022